Drupal.behaviors.print = function(context) {window.print();window.close();}>
Divesting its Communications Business, Simulations Plus Focuses on Pharmaceutical Market
November 18, 2011
Divesting its Communications Business, Simulations Plus Focuses on Pharmaceutical Market
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Certara Acquires Simcyp to Create Integrated Drug Discovery and Development Software Platform
March 2, 2012 / BioInform
Imperium Secures Assets of Bankrupt Entelos with $1.95M Credit Bid
September 30, 2011 / BioInform
Simulations Plus Submits Bid to Buy Assets of Bankrupt Entelos
September 23, 2011 / BioInform
Downloads and Upgrades: Cytoscape.js 2.0.0, ChemAxon 6.0, Floragenex Analytics Service, and more
May 31, 2013 / BioInform
Entelos, ISB Partner on Gene Expression Biomarkers
May 14, 2013 / GenomeWeb Daily News